Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: Capsule Duloxetine 30mg: Single Dose given orally 2 hours prior to procedure
Control Intervention1: Placebo: Single Dose given orally 2 hours prior to procedure
Sponsors
Dr Shilpa H L
Eligibility
Inclusion criteria
Inclusion criteria: 1.ASA I/II 2.BMI 25 and above
Exclusion criteria
Exclusion criteria: 1.Allergy to duloxetine 2.History of chronic pain 3.Currently on serotonin norepinephrine reuptake inhibitors 4.Seizure disorder 5.Pregnancy 6.Breastfeeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Post operative myalgiaTimepoint: Myalgia Score at 24 hours after procedure | — |
Secondary
| Measure | Time frame |
|---|---|
| Severity of fasciculationsTimepoint: Fasciculations are checked after administration of succinylcholine intravenous for 1 minute | — |
Countries
India
Contacts
Public ContactDr Mamatha C N
BGS Global Institute of Medical Sciences
Outcome results
None listed